BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 9211064)

  • 21. Peroxisome proliferator-activated receptors: are they involved in atherosclerosis progression?
    Puddu P; Puddu GM; Muscari A
    Int J Cardiol; 2003 Aug; 90(2-3):133-40. PubMed ID: 12957742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptors and the control of inflammation.
    Cabrero A; Laguna JC; Vázquez M
    Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):243-8. PubMed ID: 14561188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways.
    Kliewer SA; Lehmann JM; Milburn MV; Willson TM
    Recent Prog Horm Res; 1999; 54():345-67; discussion 367-8. PubMed ID: 10548883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome proliferator-activated receptors and the cardiovascular system.
    Chen YE; Fu M; Zhang J; Zhu X; Lin Y; Akinbami MA; Song Q
    Vitam Horm; 2003; 66():157-88. PubMed ID: 12852255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs).
    Staels B; Schoonjans K; Fruchart JC; Auwerx J
    Biochimie; 1997; 79(2-3):95-9. PubMed ID: 9209702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of PPAR gamma in regulating adipocyte differentiation and insulin-responsive glucose uptake.
    Hamm JK; el Jack AK; Pilch PF; Farmer SR
    Ann N Y Acad Sci; 1999 Nov; 892():134-45. PubMed ID: 10842659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.
    Plutzky J
    Curr Atheroscler Rep; 2000 Jul; 2(4):327-35. PubMed ID: 11122762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxisome proliferator-activated receptors: insight into multiple cellular functions.
    Escher P; Wahli W
    Mutat Res; 2000 Mar; 448(2):121-38. PubMed ID: 10725467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adipocyte differentiation and nuclear receptor].
    Hirose T; Kurebayashi S
    Nihon Rinsho; 1997 Jun; 55(6):1596-604. PubMed ID: 9200953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.
    Forman BM; Tontonoz P; Chen J; Brun RP; Spiegelman BM; Evans RM
    Cell; 1995 Dec; 83(5):803-12. PubMed ID: 8521497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects.
    Auwerx J; Schoonjans K; Fruchart JC; Staels B
    J Atheroscler Thromb; 1996; 3(2):81-9. PubMed ID: 9226459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptors: from genes to physiology.
    Kliewer SA; Xu HE; Lambert MH; Willson TM
    Recent Prog Horm Res; 2001; 56():239-63. PubMed ID: 11237216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling.
    Desvergne B; IJpenberg A; Devchand PR; Wahli W
    J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):65-74. PubMed ID: 9699859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPAR: a mediator of peroxisome proliferator action.
    Green S
    Mutat Res; 1995 Dec; 333(1-2):101-9. PubMed ID: 8538617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia.
    Narravula S; Colgan SP
    J Immunol; 2001 Jun; 166(12):7543-8. PubMed ID: 11390509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis.
    Fruchart JC; Duriez P; Staels B
    Curr Opin Lipidol; 1999 Jun; 10(3):245-57. PubMed ID: 10431661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha.
    Zhang B; Berger J; Hu E; Szalkowski D; White-Carrington S; Spiegelman BM; Moller DE
    Mol Endocrinol; 1996 Nov; 10(11):1457-66. PubMed ID: 8923470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.
    Krey G; Braissant O; L'Horset F; Kalkhoven E; Perroud M; Parker MG; Wahli W
    Mol Endocrinol; 1997 Jun; 11(6):779-91. PubMed ID: 9171241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis.
    Neve BP; Fruchart JC; Staels B
    Biochem Pharmacol; 2000 Oct; 60(8):1245-50. PubMed ID: 11007963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-activated receptor isoform expression changes in human gestational tissues with labor at term.
    Berry EB; Eykholt R; Helliwell RJ; Gilmour RS; Mitchell MD; Marvin KW
    Mol Pharmacol; 2003 Dec; 64(6):1586-90. PubMed ID: 14645690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.